| Description | The product SIRGT41440WQ-2OMe is a type of small interfering RNA (siRNA) that targets HRASLS2 gene and regulates the expression of gene. The siRNA interferes with the expression of HRASLS2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. TheThe product SIRGT41440WQ-2OMe is a type of small interfering RNA (siRNA) that targets HRASLS2 gene and regulates the expression of gene. The siRNA interferes with the expression of HRASLS2 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is designed with 2_-O-methyl (2'-OMe) modification to provide increased stability, increased specificity and reduced immunogenicity. It has potential applications in RNA interference (RNAi) and gene therapy development.... Read More | Creative Biolabs offers the overexpression HEK293 cells stably expressing additional TLR or NOD genes. | This product GTTS-WK5890MR is a type of mRNA having 30 nt poly(A) tail and modified with Cap 1 & N1-Methylpseudo-UTP. It ecodes the IL-4 protein. This product can be used in -related researches. | This product GTVCR-WQ39MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the T7 promoter to efficiently generate mRNA with 30 nt poly(A) tail ecoding antibody This product GTVCR-WQ39MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the T7 promoter to efficiently generate mRNA with 30 nt poly(A) tail ecoding antibody which targeting VEGFA. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.... Read More | Creative Biolabs' Neuropathy Frozen Tissue Panels are designed for the study of Alzheimer's disease, Parkinson's disease, dementia, multiple sclerosis, progressive supranuclear palsy (PSP) and depression. |